Based on the molecular characterization of WFS1 p.R558C, we hypothesized a combination treatment of 2 chemical chaperones, 4-PBA and TUDCA, could provide a treatment for Wolfram syndrome. This evidence concerns the gene WFS1 and Wolfram syndrome.